search
Back to results

RCT to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy (FIXTER-2)

Primary Purpose

Median Sternotomy

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Combination of STERN FIX and wires
Wires
Sponsored by
NEOS Surgery
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Median Sternotomy focused on measuring sternal closure, cardiac surgery, sternotomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient undergoing surgery that requires median sternotomy Patients with at least one of the following risk criteria: obesity (BMI>30), diabetes, COPD, non serious osteoporosis (not associated with fractures), creatinine > 200 µmol/L and/or under dialysis treatment, scheduled Bilateral Internal Mammary Artery (BIMA) grafting Patients willing and capable of granting informed consent to participate in clinical research and who have granted written consent Patient willing and capable of complying with the protocol requirements Exclusion Criteria: Patient with suspected or known allergies or intolerance to the device material (PEEK - polyether-ether-ketone and carbon fibre) Patient with insufficient quality or quantity of bone or any other serious structural bone damage at the sternum Patient with serious osteoporosis (associated with fractures) or a degenerative bone disease affecting the sternum Patients with a latent or active infection or inflammation at the surgical area, that according to the surgeon criteria may interfere in the device implantation or proper function. Patient with sternal anomalies that, according to the surgeon criteria, prevent the use of the product, such as bone tumours in the implantation area. Pregnant patients or patients planning to become pregnant during the first 6 months after surgery. Patients with diagnosis of dementia with a mental status score (MMSE) < 20. Patients with life expectancy lower than 6 months. Patients involved in other interventionist clinical trials or that have been involved in other interventionist clinical trials during the previous 4 weeks Parasternal sternotomy. Patients with intraoperative conditions that, according to the surgeon's opinion, require or exclude the use of a specific sternal closure system, or that cannot be closed following the study products instructions for use. IMPORTANT: When the allocated closure method is wires only, the surgeon must assess whether the patient could have also had STERN FIX implanted in order to decide if the patient can continue in the study.

Sites / Locations

  • Universitätsklinikum Freiburg
  • Complejo Hospitalario de NavarraRecruiting
  • Hospital Clínic de BarcelonaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

STERN FIX

Wires

Arm Description

Combination of at least one STERN FIX device and surgical wires to close median sternotomy (total of 5 fixation points)

Standard of care median sternotomy closure method with surgical wires

Outcomes

Primary Outcome Measures

Sternal stability
The primary outcome of this study will evaluate the sternal stability through clinical assessment using the sternal instability scale (SIS) with grades 0 to 3 where 0 is "Clinically stable sternum" and 3 is "Completely separated sternum - entire length"

Secondary Outcome Measures

Safety SAE/AE prevalence
All adverse events occurring during the study period will be recorded, except for frequent events after surgical interventions requiring median sternotomy.
Safety SAE/AE causality
All adverse events occurring during the study period will be recorded, except for frequent events after surgical interventions requiring median sternotomy.
Prevalence of device deficiencies
Adverse event related to the use of an investigational medical device. This includes adverse events resulting from insufficient or inadequate instructions for use, deployment, implantation, installation, or operation, or any malfunction and events resulting from use error or from intentional misuse of the investigational medical device.
Reinterventions - prevalence
Prevalence of reinterventions
Reinterventions - Causality
Causality of reinterventions
Prevalence of sternal wound infections
Prevalence of sternal superficial and deep wound infections
Prevalence of dehiscence
Prevalence of dehiscence (without infection)
Sternal closure time
Measured time from the implantation of the first wire to the closure of the last wire (minutes)
Easiness of use of the closure method
The surgeon perceived difficulty of the sternal closure method will be recorded using the Likert scale (1 to 5).
Surgeon satisfaction of the closure method
General surgeon satisfaction with the sternotomy closure method will be recorded using the Likert scale (1 to 5).
Chest pain
Patients will assess their chest pain using the NRS (0 to 10) while resting and after forced cough
Blood loss
Total blood loss volume obtained from thoracic drainage during the first 12 hours postoperatively will be recorded (mL).
Upper Limb functional index
Patients will assess their upper limbs functional capacity using the Upper Limb functional index (ULFI-Sp)
Quality of life - EQ5D5L
Patients will complete the EQ-5D-5L questionnaire
Sternal halves union/malunion
Using CT scan images, the separation between the two sternal halves will be measured in mm. Later on, these measurements will be classified as: Malunion: more than 3mm of separation Mild malunion: between 1 and 3mm of separation Union: less than 1mm of separation
Sternal halves alignment
Using CT scan images, the alignment between the two sternal halves will be assessed and classified as: Misalignment: <50% alignment between sternal halves Aligned: >50% de alignment between halves
Sternum integrity
Using CT scan images, the presence of bone cuts, fractures or necrosis will be assessed.
Closure system integrity
Using CT scan images, the sternal closure devices integrity will be assessed

Full Information

First Posted
July 3, 2023
Last Updated
October 17, 2023
Sponsor
NEOS Surgery
Collaborators
Hospital Clinic of Barcelona, Complejo Hospitalario de Navarra, Universitätsklinikum Freiburg
search

1. Study Identification

Unique Protocol Identification Number
NCT05953259
Brief Title
RCT to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy
Acronym
FIXTER-2
Official Title
Randomised Controlled Clinical Trial to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 27, 2023 (Actual)
Primary Completion Date
September 30, 2024 (Anticipated)
Study Completion Date
March 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NEOS Surgery
Collaborators
Hospital Clinic of Barcelona, Complejo Hospitalario de Navarra, Universitätsklinikum Freiburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare the safety and performance of the sternal stabilization system STERN FIX with the standard of care (sternal closure with wires only) in normal conditions of use, in patients of risk undergoing median sternotomy during cardiothoracic surgery. The main question it aims to answer is: • whether STERN FIX is a safe and efficient device to close the sternum after a sternotomy in patients of risk, achieving higher sternal stability than wires one month after surgery Participants will have their median sternotomy closed using STERN FIX in combination with wires or wires only at the end of their cardiothoracic surgery, according to the allocated treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Median Sternotomy
Keywords
sternal closure, cardiac surgery, sternotomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Participants and primary outcome assessors will not know whether the allocated sternotomy closure system is STERN FIX or wires only.
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
STERN FIX
Arm Type
Active Comparator
Arm Description
Combination of at least one STERN FIX device and surgical wires to close median sternotomy (total of 5 fixation points)
Arm Title
Wires
Arm Type
Active Comparator
Arm Description
Standard of care median sternotomy closure method with surgical wires
Intervention Type
Device
Intervention Name(s)
Combination of STERN FIX and wires
Intervention Description
Closure of the median sternotomy using a combination of at least one STERN FIX device and wires for a total of 5 fixation points.
Intervention Type
Device
Intervention Name(s)
Wires
Intervention Description
Closure of the median sternotomy using the standard of care with steel wires.
Primary Outcome Measure Information:
Title
Sternal stability
Description
The primary outcome of this study will evaluate the sternal stability through clinical assessment using the sternal instability scale (SIS) with grades 0 to 3 where 0 is "Clinically stable sternum" and 3 is "Completely separated sternum - entire length"
Time Frame
1 month after surgery
Secondary Outcome Measure Information:
Title
Safety SAE/AE prevalence
Description
All adverse events occurring during the study period will be recorded, except for frequent events after surgical interventions requiring median sternotomy.
Time Frame
6 months after surgery
Title
Safety SAE/AE causality
Description
All adverse events occurring during the study period will be recorded, except for frequent events after surgical interventions requiring median sternotomy.
Time Frame
6 months after surgery
Title
Prevalence of device deficiencies
Description
Adverse event related to the use of an investigational medical device. This includes adverse events resulting from insufficient or inadequate instructions for use, deployment, implantation, installation, or operation, or any malfunction and events resulting from use error or from intentional misuse of the investigational medical device.
Time Frame
6 months after surgery
Title
Reinterventions - prevalence
Description
Prevalence of reinterventions
Time Frame
6 months after surgery
Title
Reinterventions - Causality
Description
Causality of reinterventions
Time Frame
6 months after surgery
Title
Prevalence of sternal wound infections
Description
Prevalence of sternal superficial and deep wound infections
Time Frame
1 month and 6 months after surgery
Title
Prevalence of dehiscence
Description
Prevalence of dehiscence (without infection)
Time Frame
1 month and 6 months after surgery
Title
Sternal closure time
Description
Measured time from the implantation of the first wire to the closure of the last wire (minutes)
Time Frame
Surgery
Title
Easiness of use of the closure method
Description
The surgeon perceived difficulty of the sternal closure method will be recorded using the Likert scale (1 to 5).
Time Frame
Surgery
Title
Surgeon satisfaction of the closure method
Description
General surgeon satisfaction with the sternotomy closure method will be recorded using the Likert scale (1 to 5).
Time Frame
Surgery
Title
Chest pain
Description
Patients will assess their chest pain using the NRS (0 to 10) while resting and after forced cough
Time Frame
Before surgery, 3 and 7 days postoperatively, during the first month and during 6 months postoperatively
Title
Blood loss
Description
Total blood loss volume obtained from thoracic drainage during the first 12 hours postoperatively will be recorded (mL).
Time Frame
During the first 12 hours postoperatively
Title
Upper Limb functional index
Description
Patients will assess their upper limbs functional capacity using the Upper Limb functional index (ULFI-Sp)
Time Frame
Before surgery, one month and 6 months postoperatively
Title
Quality of life - EQ5D5L
Description
Patients will complete the EQ-5D-5L questionnaire
Time Frame
Before surgery, one month and 6 months postoperatively
Title
Sternal halves union/malunion
Description
Using CT scan images, the separation between the two sternal halves will be measured in mm. Later on, these measurements will be classified as: Malunion: more than 3mm of separation Mild malunion: between 1 and 3mm of separation Union: less than 1mm of separation
Time Frame
6 months after surgery
Title
Sternal halves alignment
Description
Using CT scan images, the alignment between the two sternal halves will be assessed and classified as: Misalignment: <50% alignment between sternal halves Aligned: >50% de alignment between halves
Time Frame
6 months after surgery
Title
Sternum integrity
Description
Using CT scan images, the presence of bone cuts, fractures or necrosis will be assessed.
Time Frame
6 months after surgery
Title
Closure system integrity
Description
Using CT scan images, the sternal closure devices integrity will be assessed
Time Frame
6 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient undergoing surgery that requires median sternotomy Patients with at least one of the following risk criteria: obesity (BMI>30), diabetes, COPD, non serious osteoporosis (not associated with fractures), creatinine > 200 µmol/L and/or under dialysis treatment, scheduled Bilateral Internal Mammary Artery (BIMA) grafting Patients willing and capable of granting informed consent to participate in clinical research and who have granted written consent Patient willing and capable of complying with the protocol requirements Exclusion Criteria: Patient with suspected or known allergies or intolerance to the device material (PEEK - polyether-ether-ketone and carbon fibre) Patient with insufficient quality or quantity of bone or any other serious structural bone damage at the sternum Patient with serious osteoporosis (associated with fractures) or a degenerative bone disease affecting the sternum Patients with a latent or active infection or inflammation at the surgical area, that according to the surgeon criteria may interfere in the device implantation or proper function. Patient with sternal anomalies that, according to the surgeon criteria, prevent the use of the product, such as bone tumours in the implantation area. Pregnant patients or patients planning to become pregnant during the first 6 months after surgery. Patients with diagnosis of dementia with a mental status score (MMSE) < 20. Patients with life expectancy lower than 6 months. Patients involved in other interventionist clinical trials or that have been involved in other interventionist clinical trials during the previous 4 weeks Parasternal sternotomy. Patients with intraoperative conditions that, according to the surgeon's opinion, require or exclude the use of a specific sternal closure system, or that cannot be closed following the study products instructions for use. IMPORTANT: When the allocated closure method is wires only, the surgeon must assess whether the patient could have also had STERN FIX implanted in order to decide if the patient can continue in the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laia Rofes Salsench, PhD
Phone
+34 93 594 47 26
Email
lrofes@neosurgery.com
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Alvarez-Berdugo, PhD
Phone
+34 93 594 47 26
Email
dalvarez@neosurgery.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Manel Castellà Pericás, MD/PhD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinikum Freiburg
City
Freiburg im Breisgau
State/Province
Baden-Württemberg
ZIP/Postal Code
79106
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gabriele Lechner, MA
Phone
+49 761 270 61960
Email
gabriele.lechner@uniklinik-freiburg.de
First Name & Middle Initial & Last Name & Degree
Matthias Eschenhagen, MD
Facility Name
Complejo Hospitalario de Navarra
City
Pamplona
State/Province
Navarra
ZIP/Postal Code
31008
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alicia Gainza Calleja
Phone
848423781
Ext
23781
Email
alicia.gainza.calleja@navarra.es
First Name & Middle Initial & Last Name & Degree
Facundo Machado Fernández, MD
Facility Name
Hospital Clínic de Barcelona
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nuria Pichel
Phone
+34 93 227 57 33
Email
pichel@clinic.cat
First Name & Middle Initial & Last Name & Degree
Laia Hernández
Phone
+34 93 227 57 33
Email
LAHERNANDEZ@clinic.cat
First Name & Middle Initial & Last Name & Degree
Manel Castellà Pericás, MD/PhD

12. IPD Sharing Statement

Learn more about this trial

RCT to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy

We'll reach out to this number within 24 hrs